Skip to Main Content

Paper Details

Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints.
Ann Neurol
7
2023
Author NameAffiliation
Richard S FinkelCenter for Experimental Neurotherapeutics, St. Jude Children's Research Hospital
Stephan Z??chnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine
  • 1 - 2

Datasets

Release 1.2